Upgrade to SI Premium - Free Trial

Cyclacel Pharmaceuticals, Inc. (CYCC) Posts Q2 Loss of 6c/Share

August 14, 2012 4:41 PM
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q2 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings